arrow
R

Rishi Patel

texas tech university health sciences center
H指数:25
被引数:2,656

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Myocardial Amyloid Burden in Transthyretin Amyloidosis

转甲状腺素蛋白淀粉样变性中的心肌淀粉样蛋白负荷

JACC
IF0
2025-11-080
OAAI
Uncertain Clinical Relevance of Serial Bone Scintigraphy Findings in Treated Transthyretin Amyloid Cardiomyopathy

治疗后转甲状腺素蛋白淀粉样变性心肌病中连续骨闪烁显像结果的临床相关性不确定

2025-07-090
OAAI
Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonance

Patel, R.K.; Ioannou, A.; Sheikh, A.; Razvi, Y.; Mansell, J.; Martinez-Naharro, A.; Knight, D.; Kotecha, T.; Porcari, A.; Chacko, L.; 等. 甲状腺素转运蛋白淀粉样变性心肌病:基于心血管磁共振的自然病程及治疗反应评估。Eur. Heart J. 2025, ehaf412. [Google Scholar] [CrossRef] [PubMed]

2025-07-014
OAAI
Effect of Acoramidis on Myocardial Structure and Function in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Cardiac Magnetic Resonance (CMR) Substudy
2024-12-010
PRE
Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis
2024-11-010
OAAI
Microvascular obstruction in cardiac amyloidosis

心脏淀粉样变性的微血管阻塞

2024-10-180
OA
Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis
2024-04-013
PRE
Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac Amyloidosis
2024-02-208
OAAI
Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?

p.(V142I) 相关变异型甲状腺素运载蛋白淀粉样心肌病的深度表型: 与野生型甲状腺素运载蛋白淀粉样变性不同?

2024-01-2810
OA
Myocardial perfusion in cardiac amyloidosis
2024-01-216
OA
Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importance
2023-12-185
OA
Redefining Cardiac Involvement in Systemic Immunoglobulin Light Chain Amyloidosis and Treatment Implications
2023-11-070
PRE
Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping
2023-09-0114
OAAI
Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping
2023-08-0113
OAAI
Antibody-Associated Reversal of ATTR Amyloidosis-Related Cardiomyopathy
2023-06-0825
OA
Conventional heart failure therapy in cardiac ATTR amyloidosis

心脏ATTR淀粉样变性的常规心力衰竭治疗

2023-05-2242
OAAI